Sophie has over 20 years’ experience in Venture Capital where she was Founder and General Partner of Banexi Ventures Partners (now named Kreaxi). She recently joined BNPPARIBAS Développement to start venture capital investment in healthcare. She holds a PhD in Pharmacy at Paul Sabatier University in Toulouse and a Master’s degree in Biopharmaceutical management at ESCP Europe. Her current portfolio includes Aleva Therapeutics, Eyetechcare, Screencell, Ciliatech, Medincell, Sensome, Antabio and Stilla Technologies.
